ZIDOVUDINE VS 2,3-DIDEHYDRO-3 DEOXYTHYMIDINE IN HIV+ CHILDREN

齐多夫定 VS 2,3-二氢-3 脱氧胸苷治疗 HIV 儿童

• 批准号: 3742165
• 负责人: MARK W KLINE
• 金额: --
• 依托单位: BAYLOR COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3742165
• 关键词: 2'3' dideoxynucleoside; AIDS therapy; HIV infections; antiAIDS agent; antiviral agents; child (0-11); drug screening /evaluation; human subject; human therapy evaluation; pediatric AIDS; pediatric pharmacology; zidovudine

The relative safety and tolerance of the new antiretroviral agent, d4T, are compared with that of ZDV in the treatment of symptomatic HIV infection in children.

新的抗逆转录病毒药物d4T的相对安全性和耐受性， 与ZDV治疗症状性HIV的疗效进行了比较 儿童感染。